source
- Biotech VC Forbion raises record €2.3 bn ($2.6 bn) to back 30 high-potential life-science companiesForbion announced a record fundraising of €2.3 bn ($2.6 bn) across two new funds, bringing its assets under management to about €7.5 bn ($8.4 bn). The capital will be allocated through the Forbion…
- TCGX launches $600 million Asia-focused biotech fund to back life-science companies in China and the regionTCGX, a biotech investment firm led by Chen Yu and Dandan Dong, announced a new $600 million fund aimed at the Asian market. The fund will make direct investments in life-science companies located…